1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. OPUS GENETICS INC.
Opus Genetics Inc.
XNAS: IRD
4.76 -0.11 (-2.26%)
1.2M
XNAS Volume

XNAS 25 Sep, 2026 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Opus Genetics Inc is on 04 Oct 2026 for the purpose of Euretina 2026 See details

Opus Genetics Inc - IRD - stock price prediction, stock price target, analyst ratings from 18 analysts

Opus Genetics Inc has a share price target of US$ 13, revenue growth forecast of -7.7%, and profit growth estimate of -85.4% for FY26, based on top 18 analyst calls.